Topamax, Topiramate Wire

Comprehensive News Feed for Topamax, Topiramate (generic).

Results 1 - 20 of 73 in Topamax, Topiramate (generic)

1. Off-label drug use raises safety concerns

   4 hrs ago | Canada.com

   Susan Dudley, a nurse, became depressed and suicidal after taking a medication, prescribed to her for pain but not approved for such use.

   Comment?

   Related Topix: Medicine, Neurontin, Gabapentin (generic), Medication, Food and Drug Administration

2. Band-Aid Won't Stop Generic Bleeding at Johnson & Johnson

   Wednesday Nov 11 | BNET

   Despite best efforts to build a diversified health care business, the fortunes of Johnson & Johnson remain tethered to prescription drug sales, which comprise almost 40 percent of total revenue.

   Comment?

   Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Food, J and J Snack Foods, Medication, Risperdal, Risperidone (generic), Ritalin, Methylphenidate (generic)

3. Johnson & Johnson to Overhaul Pharma, Cut 7,000 Jobs

   Tuesday Nov 3 | BusinessWeek

   The recession has slammed Johnson & Johnson , the world's largest health-care company.

   Comment?

   Related Topix: Biotech, Johnson and Johnson, Healthcare Industry, Sales

4. J&J Plans to Lay Off 7,000

   Tuesday Nov 3 | BusinessWeek

   The recession has slammed Johnson & Johnson , the world's largest health-care company.

   Comment?

   Related Topix: Biotech, Johnson and Johnson, Healthcare Industry, Sales

5. Drug vs. Nature; who wins?

   Wednesday Oct 21 | Julia Havey-Ediets.com's Master Motivator

   October 21, 2009 Drug vs. Nature; who wins? I read an article in USAToday Losing weight is hard, and we need more tools in our toolbox to help patients," says Donna Ryan, associate executive director for clinical research at Pennington Biomedical Research Center in Baton Rouge.

   Comment?

   Related Topix: Life, Food, Dieting, Medicine, Alcoholism, Phentermine (generic), Ionamin, Adipex-P, Medication, Epilepsy

6. Sandoz launches two products

   Monday Oct 19 | Drug Store News

   PRINCETON,A N.J. The generics arm of drug maker Novartis has launched two new products.

   Comment?

   Related Topix: Medicine, Alcoholism, Health, Medication, Epilepsy

7. Should I move to a different state?

   Friday Oct 16 | HealthCentral

   Should I move to a different state? 10/16/09 Hopeful Topics: Environment I recently spent a year in Colorado.

   Comment?

   Related Topix: Migraine, Health, Medication

8. Larry Birkhead: Anna Nicole Suffered Seizures, Popped Pills on Daily Basis w/Photo

   Friday Oct 16 | E! Online

   Today's star attraction in the Anna Nicole Smith drug-plying case/circus : none other than her baby daddy Larry Birkhead .

   Comment?

   Related Topix: Medicine, Seizures, Health, Drugs, Methadone, Medication, Klonopin, Clonazepam (generic), Valium, Valrelease, Diazepam (generic)

9. FDA approves generic epilepsy treatment

   Thursday Oct 15 | Drug Store News

   PITTSBURGH Generic drug maker Mylan has received the Food and Drug Administrationa s approval for its version of a drug used to treat epilepsy.

   Comment?

   Related Topix: Epilepsy, Medicine, Health, Alcoholism, Medication

10. Health-Care Stocks: A Dose of Reality from J&J

    Oct 13, 2009 | BusinessWeek

    It's likely to be some time before health-care companies begin to enjoy the fruits of any economic recovery, judging by Johnson & Johnson's slight third-quarter revenue miss on Oct.

    Comment?

    Related Topix: Food, J and J Snack Foods, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, 9

11. J&J Needs to Get Drugged Up

    Oct 13, 2009 | Fool.com

    Johnson & Johnson needs a pep pill. For the second quarter in a row, revenue from medical devices and diagnostics came in higher than the revenue supplied by its pharmaceutical segment.

    Comment?

    Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Epilepsy, Health, Medication, ADHD, Schering Plough, Merck

12. J&J reports higher earnings, despite lower sales

    Oct 13, 2009 | MarketWatch

    Johnson & Johnson early Tuesday reported moderately higher third-quarter earnings, but its sales performance was tempered by declining sales of two of its top-selling prescription drugs, Topamax and Risperdal, due to increased generic competition.

    Comment?

    Related Topix: Food, J and J Snack Foods, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Medication

13. Johnson & Johnson Reports 2009 Third-Quarter Results:

    Oct 13, 2009 | PR Newswire

    Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008.

    Comment?

    Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Medication, Risperdal, Risperidone (generic), Food and Drug Administration

14. Cost Cuts Help J&J Profit, Sales Disappoint

    Oct 13, 2009 | Fox News

    Consumer products and pharmaceutical giant Johnson & Johnson posted a 1.1% rise in quarterly profit on Tuesday, however revenue came in short of analysts' estimates as some of the company's biggest drugs hit the generic market.

    Comment?

    Related Topix: Food, J and J Snack Foods, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Business News

15. J&J Profit Rises on Higher Device Sales, Cost Cutting; '09 Forecast Raised

    Oct 13, 2009 | Bloomberg

    Johnson & Johnsona s profit rose 1.1 percent as cost cutting and sales of medical devices offset drug revenue lost to generic competition.

    Comment?

    Related Topix: Food, J and J Snack Foods, New Brunswick, NJ, US News

16. Does anyone have a cyst on pineal gland?

    Oct 17, 2008 | HealthCentral

    Does anyone have a cyst on pineal gland? 10/17/08 T Topics: pineal cyst I got my second MRI in the past 5 years and suffer from severe migraines on the left side of my head along with eye drooping.

    Comment?

17. J&J faces pain from generic rivals

    Oct 8, 2009 | MarketWatch

    Healthcare products giant Johnson & Johnson is expected to report moderately lower third-quarter earnings Tuesday, due in part to the loss of patent protection on such top-grossing drugs as Risperdal and Topamax.

    Comment?

    Related Topix: Food, J and J Snack Foods, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Medication, Epilepsy, Health, Schering Plough

18. Earnings Outlook: J&J results expected to be pressured by generics

    Oct 8, 2009 | MarketWatch

    Healthcare products giant Johnson & Johnson is expected to report moderately lower third-quarter earnings Tuesday, due in part to the loss of patent protection on such top-grossing drugs as Risperdal and Topamax.

    Comment?

    Related Topix: Food, J and J Snack Foods, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Medication, Epilepsy, Health, Schering Plough

19. How to Play It: Johnson & Johnson

    Oct 1, 2009 | BusinessWeek

    Shares of Johnson & Johnson didna t hold up as well during last yeara s market plunge as they did in prior downturns.

    Comment?

    Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Food, J and J Snack Foods, Epilepsy, Health

20. Epileptic Drugs Responsible for Risks in Pregnancy Not Epilepsy

    Sep 23, 2009 | EMaxHealth

    There are 38 countries participating in EURAP which is an international antiepileptic drug and pregnancy registry, 1999 to 2005.

    Comment?

    Related Topix: Epilepsy, Medicine, Health, Lamictal, Lamotrigine (generic)